🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This observational study will evaluate the efficacy and safety of bevacizum...
Status
Completed
Location
Clinique Esquirol Saint Hilaire
Start Date
2010-09-30
Trial ID
NCT01343901
Treatments Being Tested
The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg ...
Status
Completed
Location
Simbec Research Ltd (Simbec)
Start Date
2018-06-11
Trial ID
NCT07173738
Treatments Being Tested
This is a single-center, open-label, phase I clinical trial aimed to evalua...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-08-01
Trial ID
NCT05507606
Treatments Being Tested
Rationale Acute ischemic stroke due to atrial fibrillation (AF) carries a h...
Status
Completed
Location
Asan Medical Center
Start Date
2014-01
Trial ID
NCT02042534
Treatments Being Tested
The study proposes to assess the effect of multiple applications of antimic...
Status
Completed
Location
Mariana Sales
Start Date
2014-09-01
Trial ID
NCT03039244
Treatments Being Tested
The objective of this study is to investigate psychometric properties of du...
Status
Completed
Location
Chang Gung University
Start Date
2018-08-06
Trial ID
NCT03614182
This study will be a two-part with an open-label, single oral dose, two-way...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-11
Trial ID
NCT02371603
This study aims to observe and evaluate the efficacy and safety of the peri...
Status
Terminated
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2020-12-26
Trial ID
NCT04653389
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
In order to assess the potential impact of steady state BI 425809 on CYP3A ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-03-18
Trial ID
NCT05258110
Treatments Being Tested